Amyloidosis.
Bustamante JG, Zaidi SRH.
2023 Jul 31. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–.
Expert consensus recommendations to improve diagnosis of ATTR amyloidosis with polyneuropathy.
Adams D, Ando Y, Beirão JM, Coelho T, Gertz MA, Gillmore JD, Hawkins PN, Lousada I, Suhr OB, Merlini G.
J Neurol. 2021 Jun;268(6):2109-2122. doi: 10.1007/s00415-019-09688-0. Epub 2020 Jan 6.
Hereditary Transthyretin Amyloidosis.
Sekijima Y, Nakamura K.
2001 Nov 5 [updated 2024 May 30]. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2025.
Vitreous Amyloidosis: Ocular, Systemic, and Genetic Insights.
Venkatesh P, Selvan H, Singh SB, Gupta D, Kashyap S, Temkar S, Gogia V, Tripathy K, Chawla R, Vohra R.
Ophthalmology. 2017 Jul;124(7):1014-1022. doi: 10.1016/j.ophtha.2017.03.011. Epub 2017 Apr 12.
Retrolental amyloidosis of the vitreous body (case study).
Shaimova VA, Nosul YV, Kuchkildina SK, Kulikov AN, Maltsev DS, Shaimov TB, Shaimov RB, Golovneva ES, Kravchenko TG, Kholopova AY, Ermilov VV, Berdnikov RB.
Vestn Oftalmol. 2021;137(4):98-103. doi: 10.17116/oftalma202113704198.
Ocular amyloidosis, with special reference to the hereditary forms with vitreous involvement.
Sandgren O.
Surv Ophthalmol. 1995 Nov-Dec;40(3):173-96. doi: 10.1016/s0039-6257(95)80025-5.
Rare manifestation of familial vitreous amyloidosis caused by Gly103Arg transthyretin.
Feng YB, Shi YB, He YY, Ma ZY, Zhu YX, Weng WQ.
Int J Ophthalmol. 2023 Jul 18;16(7):1093-1099. doi: 10.18240/ijo.2023.07.14. eCollection 2023.
Vitreous amyloidosis caused by a Lys55Asn variant in transthyretin: A case report.
Tan Y, Tao Y, Sheng YJ, Zhang CM.
World J Clin Cases. 2022 Nov 16;10(32):12000-12006. doi: 10.12998/wjcc.v10.i32.12000.
Retrolenticular Vitreous Opacities as a Diagnostic Indicator of Systemic Amyloidosis.
Abramowitz C, Chin EK, Almeida DRP.
J Vitreoretin Dis. 2022 Aug 8;6(5):405-408. doi: 10.1177/24741264221079718. eCollection 2022 Sep-Oct.
Vitreous amyloidosis as primary manifestation of disease: case report.
García Franco R, Arias Gómez A, García Roa M, Ramírez Neria P, Corredor Casas S.
Arch Soc Esp Oftalmol (Engl Ed). 2020 May;95(5):244-247. doi: 10.1016/j.oftal.2019.12.019. Epub 2020 Mar 4.
